Frontline Ltd. (NYSE: FRO) ("Frontline" or the "Company") today announced the
Company entered into an Equity Distribution Agreement dated July 24, 2018, with
Morgan Stanley & Co. LLC ("Morgan Stanley") for the offer and sale of up to
$100.0 million of common shares of Frontline.

In accordance with the terms of the Equity Distribution Agreement, the Company
may offer and sell its common shares at any time and from time to time through
Morgan Stanley as its sales agent. Sales of the common shares, if any, will be
made by means of ordinary brokers' transactions on NYSE or otherwise at market
prices prevailing at the time of sale, at prices related to the prevailing
market prices, or at negotiated prices.

The net proceeds of this offering will be used to opportunistically fund growth
opportunities, for certain capital expenditures, including to purchase exhaust
gas cleaning systems that reduce sulfur emissions to comply with upcoming
implementation of new IMO standards, and for general corporate purposes.

This press release does not constitute an offer to sell or the solicitation of
an offer to buy securities and shall not constitute an offer, solicitation or
sale in any jurisdiction in which such offer, solicitation or sale is unlawful.
The offering is being made by means of a prospectus and related prospectus
supplement. A prospectus supplement related to the offering has been filed with
the Securities and Exchange Commission. Copies of the prospectus and prospectus
supplement relating to the offering may be obtained from the offices of Morgan
Stanley at 180 Varick Street, Second Floor, New York, New York 10014, Attention:
Prospectus Department.

July 24, 2018
The Board of Directors
Frontline Ltd.
Hamilton, Bermuda